BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peled Y, Ram E, Lavee J, Segev A, Matezki S, Wieder-Finesod A, Halperin R, Mandelboim M, Indenbaum V, Levy I, Sternik L, Raanani E, Afek A, Kreiss Y, Lustig Y, Rahav G. Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience. J Heart Lung Transplant 2021:S1053-2498(21)02481-5. [PMID: 34565682 DOI: 10.1016/j.healun.2021.08.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 39.0] [Reference Citation Analysis]
Number Citing Articles
1 Chi X, Gu J, Ma X. Characteristics and Roles of T Follicular Helper Cells in SARS-CoV-2 Vaccine Response. Vaccines 2022;10:1623. [DOI: 10.3390/vaccines10101623] [Reference Citation Analysis]
2 Gyftopoulos A, Ziogas IA, Montenovo MI. Liver transplantation during COVID-19: Adaptive measures with future significance. World J Transplant 2022; 12(9): 288-298 [DOI: 10.5500/wjt.v12.i9.288] [Reference Citation Analysis]
3 El-Menyar A, Khan NA, Mekkodathil A, Rizoli S, Consunji R, Elmenyar E, Galwankar S, Al-Thani H. A quick scoping review of the first year of vaccination against the COVID-19 pandemic: Do we need more shots or time? Medicine (Baltimore) 2022;101:e30609. [PMID: 36123868 DOI: 10.1097/MD.0000000000030609] [Reference Citation Analysis]
4 Ambrosi P, Basire A, Habib G. High rate of seroconversion after COVID-19 vaccination during the long term follow-up of heart transplant recipients. Transpl Infect Dis 2022;:e13945. [PMID: 36039842 DOI: 10.1111/tid.13945] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen J, Zhang T, Lu Y, Yang X, Ouyang Z. Emerging trends of research on mRNA vaccines: A co-citation analysis. Hum Vaccin Immunother 2022;:2110409. [PMID: 36018287 DOI: 10.1080/21645515.2022.2110409] [Reference Citation Analysis]
6 Costard-Jäckle A, Schramm R, Fischer B, Rivinius R, Bruno R, Müller B, Zittermann A, Boeken U, Westenfeld R, Knabbe C, Gummert J. Third dose of the BNT162b2 vaccine in cardiothoracic transplant recipients: predictive factors for humoral response. Clin Res Cardiol 2022. [PMID: 35994091 DOI: 10.1007/s00392-022-02075-2] [Reference Citation Analysis]
7 Sakuraba A, Luna A, Micic D. A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients. Viruses 2022;14:1822. [PMID: 36016444 DOI: 10.3390/v14081822] [Reference Citation Analysis]
8 Thümmler L, Gäckler A, Bormann M, Ciesek S, Widera M, Rohn H, Fisenkci N, Otte M, Alt M, Dittmer U, Horn PA, Witzke O, Krawczyk A, Lindemann M. Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant Patients. Vaccines 2022;10:1348. [DOI: 10.3390/vaccines10081348] [Reference Citation Analysis]
9 Miele M, Busà R, Russelli G, Sorrentino MC, Di Bella M, Timoneri F, Vitale G, Calzolari E, Vitulo P, Mularoni A, Conaldi PG, Bulati M. Analysis of the Specific Immune Response after the Third Dose of mRNA COVID-19 Vaccines in Organ Transplant Recipients: Possible Spike-S1 Reactive IgA Signature in Protection from SARS-CoV-2 Infection. Microorganisms 2022;10:1563. [DOI: 10.3390/microorganisms10081563] [Reference Citation Analysis]
10 Abuhammad S, Khabour OF, Alzoubi KH, Hamaideh S, Alzoubi BA, Telfah WS, El-Zubi FK. The public's attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan. PLoS One 2022;17:e0271625. [PMID: 35857813 DOI: 10.1371/journal.pone.0271625] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Marjot T, Eberhardt CS, Boettler T, Belli LS, Berenguer M, Buti M, Jalan R, Mondelli MU, Moreau R, Shouval D, Berg T, Cornberg M. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper. J Hepatol 2022:S0168-8278(22)02942-7. [PMID: 35868584 DOI: 10.1016/j.jhep.2022.07.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Haidar G. Immunity to a third BNT162B2 COVID-19 vaccine after heart transplantation: Bridging the knowledge gap to end the pandemic for organ transplant recipients. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.07.004] [Reference Citation Analysis]
13 Gallais F, Renaud-picard B, Solis M, Laugel E, Soulier E, Caillard S, Kessler R, Fafi-kremer S. Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.07.008] [Reference Citation Analysis]
14 Li J, Ayada I, Wang Y, den Hoed CM, Kamar N, Peppelenbosch MP, de Vries AC, Li P, Pan Q. Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysis. Transplantation 2022. [PMID: 35761439 DOI: 10.1097/TP.0000000000004256] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Pani A, Romandini A, Schianchi A, Senatore M, Gagliardi OM, Gazzaniga G, Agliardi S, Conti T, Schenardi PA, Maggi M, D'Onghia S, Panetta V, Renica S, Molteni SN, Vismara C, Campisi D, Bertuzzi M, Giroldi S, Zoppini L, Moreno M, Merli M, Bosio M, Puoti M, Scaglione F. Antibody Response to COVID-19 Booster Vaccination in Healthcare Workers. Front Immunol 2022;13:872667. [PMID: 35720366 DOI: 10.3389/fimmu.2022.872667] [Reference Citation Analysis]
16 Svorcova M, Novysedlak R, Lischke R, Vachtenheim J Jr, Strizova Z. Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety. Front Immunol 2022;13:906225. [PMID: 35720376 DOI: 10.3389/fimmu.2022.906225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Thümmler L, Koldehoff M, Fisenkci N, Brochhagen L, Horn PA, Krawczyk A, Lindemann M. Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients. Vaccines (Basel) 2022;10:972. [PMID: 35746580 DOI: 10.3390/vaccines10060972] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Arenas-De Larriva M, Rodríguez-Perálvarez ML. Mycophenolate and SARS-CoV-2 vaccination: Mixing oil and water. Liver Int 2022;42:1218-21. [PMID: 35678038 DOI: 10.1111/liv.15265] [Reference Citation Analysis]
19 Altneu E, Mishkin A. COVID-19 Vaccination in Lung Transplant Recipients. Indian J Thorac Cardiovasc Surg. [DOI: 10.1007/s12055-022-01364-9] [Reference Citation Analysis]
20 Peled Y, Afek A, Nemet I, Rahav G, Raanani E, Patel JK, Mandelboim M. Fourth BNT162b2 Vaccination Neutralization of Omicron Infection after Heart Transplantation. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.04.014] [Reference Citation Analysis]
21 Manothummetha K, Chuleerarux N, Sanguankeo A, Kates OS, Hirankarn N, Thongkam A, Dioverti-Prono MV, Torvorapanit P, Langsiri N, Worasilchai N, Moonla C, Plongla R, Garneau WM, Chindamporn A, Nissaisorakarn P, Thaniyavarn T, Nematollahi S, Permpalung N. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis. JAMA Netw Open 2022;5:e226822. [PMID: 35412626 DOI: 10.1001/jamanetworkopen.2022.6822] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
22 Aikawa NE, Kupa LDVK, Medeiros-ribeiro AC, Saad CGS, Yuki EFN, Pasoto SG, Rojo PT, Pereira RMR, Shinjo SK, Sampaio-barros PD, Andrade DCO, Halpern ASR, Fuller R, Souza FHC, Guedes LKN, Assad APL, Moraes JCBD, Lopes MRU, Martins VADO, Betancourt L, Ribeiro CT, Sales LP, Bertoglio IM, Bonoldi VLN, Mello RLP, Balbi GGM, Sartori AMC, Antonangelo L, Silva CA, Bonfa E. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Ann Rheum Dis. [DOI: 10.1136/annrheumdis-2021-222096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
23 Salleh MZ, Norazmi MN, Deris ZZ. Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2. PeerJ 2022;10:e13083. [DOI: 10.7717/peerj.13083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Baron F, Canti L, Ariën KK, Kemlin D, Desombere I, Gerbaux M, Pannus P, Beguin Y, Marchant A, Humblet-baron S. Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients. Front Immunol 2022;13:827242. [DOI: 10.3389/fimmu.2022.827242] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Romero-Ibarguengoitia ME, Rivera-Salinas D, Hernández-Ruíz YG, Armendariz-Vázquez AG, González-Cantú A, Barco-Flores IA, González-Facio R, Montelongo-Cruz LP, Del Rio-Parra GF, Garza-Herrera MR, Leal-Meléndez JA, Sanz-Sánchez MÁ. Effect of the third dose of BNT162b2 vaccine on quantitative SARS-CoV-2 spike 1-2 IgG antibody titers in healthcare personnel. PLoS One 2022;17:e0263942. [PMID: 35235587 DOI: 10.1371/journal.pone.0263942] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
26 Lee ARYB, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, Tay SH, Teo CB, Tan BKJ, Chan YH, Sundar R, Soon YY. Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ 2022;376:e068632. [PMID: 35236664 DOI: 10.1136/bmj-2021-068632] [Cited by in Crossref: 50] [Cited by in F6Publishing: 24] [Article Influence: 50.0] [Reference Citation Analysis]
27 Dhand A, Razonable RR. COVID-19 and Solid Organ Transplantation: Role of Anti-SARS-CoV-2 Monoclonal Antibodies. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00357-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
28 Burckhardt RM, Dennehy JJ, Poon LLM, Saif LJ, Enquist LW. Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters. J Virol 2021;:JVI0197321. [PMID: 34817198 DOI: 10.1128/JVI.01973-21] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
29 Kumar D, Ferreira VH, Hall VG, Hu Q, Samson R, Ku T, Ierullo M, Majchrzak-Kita B, Tomlinson G, Gingras AC, Humar A. Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial. Ann Intern Med 2021. [PMID: 34807716 DOI: 10.7326/M21-3480] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 21.0] [Reference Citation Analysis]
30 Liu Q, Qin C, Liu M, Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infect Dis Poverty 2021;10:132. [PMID: 34776011 DOI: 10.1186/s40249-021-00915-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]